MedPath

Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE

Phase 4
Terminated
Conditions
Labor Pain
Interventions
Registration Number
NCT01005459
Lead Sponsor
Wake Forest University
Brief Summary

The investigators hypothesis is that spinal tetracaine with fentanyl and epinephrine used for CSE labor analgesia volume will last a significantly longer period of time that that of spinal bupivacaine with fentanyl. After informed consent is obtained for the study, subjects meeting criteria when analgesia is requested will be randomized to receive a combined spinal-epidural containing either tetracaine 2 mg with fentanyl and epinephrine or bupivacaine 2 mg with fentanyl and epinephrine.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
46
Inclusion Criteria
  • early labor (>=2cm but =<6cm cervical dilation)
  • at least 12 years of age
  • have an assigned ASA physical status 1 or 2
  • singleton pregnancy
Exclusion Criteria
  • contraindications to neuraxial anesthesia
  • with allergies to drugs used in the study
  • have an assigned ASA status 3 or 4
  • advanced labor (> 6cm cervical dilation)
  • less than 12 years of age
  • Patients with the potential for distorted epidural anatomy, such as Harrington rods or prior back surgery, will also be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
tetracaine 2mgTetracaine-
Bupivacaine 2 mgBupivacaine-
Primary Outcome Measures
NameTimeMethod
Spinal Analgesic Duration1-2 hrs

duration of time in minutes from the time the combined spinal epidural is placed until the participant requests additional analgesia; at that time the epidural was dosed and study participation was complete

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Forsyth Medical Center- OB Anesthesia dept

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath